Yahoo Finance • 1 hour ago
[Person holding tablet, business concept] ra2studio/iStock via Getty Images Major asset managers are eager to open the door for ordinary Americans to invest in private-market assets such as private equity and private credit, investments h... Full story
Yahoo Finance • 2 hours ago
[Young blond female manager explaining quarterly results on large led screen] NicolasMcComber Earnings season heats up in mid-October, featuring results from a stellar lineup of companies across various sectors. This week's highlights inc... Full story
Yahoo Finance • 2 hours ago
The stock market will enter the second full week of the government shutdown following a tariff-driven selloff Friday. At the closing bell, the S&P 500 (^GSPC), tech-heavy Nasdaq Composite (^IXIC), and small cap-focused Russell 2000 (^RUT)... Full story
Yahoo Finance • 16 hours ago
Tom Werner Wall Street's major averages plummeted on Friday after U.S. President Donald Trump threatened higher tariffs to China, saying it had "become very hostile" sending letters to other countries wanting to "impose export controls."... Full story
Yahoo Finance • 19 hours ago
Here's a list of key deals reported across sectors this week: * Protagonist Therapeutics (NASDAQ:PTGX [https://seekingalpha.com/symbol/PTGX]), a biotech focused on peptide-based therapeutics, traded ~30% higher on Friday after The Wall... Full story
Yahoo Finance • 2 days ago
NEW BRUNSWICK, N.J., October 10, 2025--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC, a limited liability company established pursuant to the... Full story
Yahoo Finance • 2 days ago
Protagonist Therapeutics shares soared more than 30% Friday after The Wall Street Journal reported that the biopharma company was in talks with Johnson & Johnson about a possible acquistion. See more ... Continue Reading Visualizza comme... Full story
Yahoo Finance • 2 days ago
Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index down 1.4% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 2 days ago
At Holdings Channel, we have reviewed the latest batch of the 20 most recent 13F filings for the 03/31/2025 reporting period, and noticed that Johnson & Johnson (Symbol: JNJ) was held by 13 of these funds. When hedge fund managers appear... Full story
Yahoo Finance • 2 days ago
Yahoo Finance Anchor Josh Lipton reports on three stories Wall Street is watching in the latest Market Minute: US stocks tumble as US-China trade tensions intensify, Protagonist Therapeutic (PTGX) shares surge on WSJ reports of acquisition... Full story
Yahoo Finance • 2 days ago
Health care stocks were lower Friday afternoon, with the NYSE Health Care Index and the Health Care PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story
Yahoo Finance • 2 days ago
Quoin Pharmaceuticals (QNRX) shares soared 126% amid heavy trading intraday after the company said F PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 2 days ago
All three major US stock indexes were in the red around midday trading Friday, with the Nasdaq Compo PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 2 days ago
Investing.com -- Protagonist Therapeutics (NASDAQ:PTGX) stock spiked 10% before being halted for volatility after The Wall Street Journal reported that Johnson & Johnson (NYSE:JNJ) is in talks to acquire the biotech company. The potential... Full story
Yahoo Finance • 2 days ago
A packed week of earnings is set to provide investors with fresh insights into the state of the global economy, as major companies across various sectors and geographies prepare to report. In the US, JPMorgan Chase (JPM), the country’s la... Full story
Yahoo Finance • 2 days ago
Protagonist Therapeutics (NASDAQ:PTGX [https://seekingalpha.com/symbol/PTGX]), a biotech focused on peptide-based therapeutics, traded ~30% higher on Friday after The Wall Street Journal reported that Johnson & Johnson (NYSE:JNJ [https://s... Full story
Yahoo Finance • 2 days ago
Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks... Full story
Yahoo Finance • 2 days ago
17 abstracts from across the Company's portfolio and pipeline highlight new clinical and real-world data on major depressive disorder and treatment-resistant depression New post-hoc analysis of CAPLYTA® (lumateperone) Phase 3 data evaluat... Full story
Yahoo Finance • 3 days ago
Cognivia Signal expected to reduce trial dropout risk and placebo impact for pharma and biotech trial sponsors. MONT-SAINT-GUIBERT, Belgium, Oct. 9, 2025 /PRNewswire/ -- Cognivia, an innovative AI company dedicated to helping clinical tri... Full story
Yahoo Finance • 3 days ago
Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks fo... Full story